Evidence map›Paper›PMID 27914984›Full record

ArticleBiomaterials2017

Recapitulating the human tumor microenvironment: Colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth.

Mónica Romero-López, Andrew L Trinh, Agua Sobrino, Michaela M S Hatch, Mark T Keating, Cristhian Fimbres, David E Lewis, Paul D Gershon, Elliot L Botvinick, Michelle Digman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. TheMaterials today. Bio · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Frontiers in genetics · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mónica Romero-LópezDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA.
Andrew L TrinhDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA.
Agua SobrinoDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA.
Michaela M S HatchDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, UC Irvine, USA.
Mark T KeatingDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA.
Cristhian FimbresDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA.
David E LewisDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, UC Irvine, USA.
Paul D GershonDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, UC Irvine, USA.
Elliot L BotvinickDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, UC Irvine, USA.
Michelle DigmanDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA.
John S LowengrubDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA; Department of Mathematics, School of Physical Sciences, UC Irvine, USA.
Christopher C W HughesDepartment of Biomedical Engineering, The Henry Samueli School of Engineering, UC Irvine, USA; Department of Molecular Biology and Biochemistry, School of Biological Sciences, UC Irvine, USA; The Edwards Lifesciences Center for Advanced Cardiovascular Technology, UC Irvine, USA. Electronic address: cchughes@uci.edu.
University of California, Irvine · USSamueli Institute · USEdwards Lifesciences (United States) · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Uncover Strategies Used By Biological SystemsP50GM076516 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LANDER, ARTHUR D · 2007 to 2016
$25.1M
TRD4: Phasor analysisP41GM103540 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GRATTON, ENRICO · 2012 to 2020
$12.5M
Virtual Photonocs TechnologiesP41EB015890 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI DURKIN, ANTHONY · 2012 to 2017
$7.0M
Regulation and Enhancement of Angiogenesis in Dense Fibrin MatricesR01HL085339 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTNAM, ANDREW J · 2007 to 2024
$5.4M
MOLECULAR APPROACHES TARGETED ON BLOCKING ANGIOGENESISR01HL060067 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUGHES, CHRISTOPHER C. W. · 1999 to 2013
$3.1M
Training Program in Cardiovascular Applied Research and EntrepreneurshipT32HL116270 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUGHES, CHRISTOPHER C. W. · 2013 to 2022
$1.6M
(PQD5) Development of in Vitro Vascularized Microtumors for Drug ScreeningR01CA180122 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUGHES, CHRISTOPHER C. W. · 2013 to 2016
$1.2M
Center for Clinical and Translational ScienceKL2TR000048 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AZAR, DIMITRI T, MERMELSTEIN, ROBIN J. · 2012 to 2014
$559k
LTQ Velos Pro mass spectrometer with ETD and other optionsS10OD016328 · OD · UNIVERSITY OF CALIFORNIA-IRVINE · PI GERSHON, PAUL D · 2013 to 2013
$374k
NCATS NIH HHS KL2 TR000048NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA180122NHLBI NIH HHS R01 HL060067NHLBI NIH HHS R01 HL085339NHLBI NIH HHS T32 HL116270NIBIB NIH HHS P41 EB015890NIGMS NIH HHS P41 GM103540NIGMS NIH HHS P50 GM076516NIH HHS S10 OD016328
6 · The paper itself

Abstract

Extracellular matrix (ECM) is an essential and dynamic component of all tissues and directly affects cellular behavior by providing both mechanical and biochemical signaling cues. Changes in ECM can alter tissue homeostasis, potentially leading to promotion of cellular transformation and the generation of tumors. Therefore, understanding ECM compositional changes during cancer progression is vital to the development of targeted treatments. Previous efforts to reproduce the native 3D cellular microenvironment have utilized protein gels and scaffolds that incompletely recapitulate the complexity of native tissues. Here, we address this problem by extracting and comparing ECM from normal human colon and colon tumor that had metastasized to liver. We found differences in protein composition and stiffness, and observed significant differences in vascular network formation and tumor growth in each of the reconstituted matrices, both in vitro and in vivo. We studied free/bound ratios of NADH in the tumor and endothelial cells using Fluorescence Lifetime Imaging Microscopy as a surrogate for the metabolic state of the cells. We observed that cells seeded in tumor ECM had higher relative levels of free NADH, consistent with a higher glycolytic rate, than those seeded in normal ECM. These results demonstrate that the ECM plays an important role in the growth of cancer cells and their associated vasculature.

Indexed as

Tumor MicroenvironmentCell ProliferationColonic NeoplasmsExtracellular MatrixHumansNeovascularization, PathologicTumor Cells, Cultured3D cell cultureColonDecellularizationECMTumor metabolismTumor microenviroment

Identifiers

PMID27914984
PMCPMC5226635
OpenAlexW2550719584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.